AAAAAA

   
Results: 1-10 |
Results: 10
THE EFFICACY OF A NEW TOPICAL TREATMENT FOR PSORIASIS - MIRAK
Authors: SEYGER MMB VANDEKERKHOF PCM VANVLIJMENWILLEMS IMJJ DEBAKKER ESM ZWIERS F DEJONG EMGJ
Citation: Mmb. Seyger et al., THE EFFICACY OF A NEW TOPICAL TREATMENT FOR PSORIASIS - MIRAK, JEADV. Journal of the European Academy of Dermatology and Venereology, 11(1), 1998, pp. 13-18
LOW-DOSE METHOTREXATE IN THE TREATMENT OF WIDESPREAD MORPHEA
Authors: SEYGER MMB VANDENHOOGEN FHJ DEBOO T DEJONG EMGJ
Citation: Mmb. Seyger et al., LOW-DOSE METHOTREXATE IN THE TREATMENT OF WIDESPREAD MORPHEA, Journal of the American Academy of Dermatology, 39(2), 1998, pp. 220-225
LOCALIZED AND SYSTEMIC SCLERODERMA SHOW DIFFERENT HISTOLOGICAL RESPONSES TO METHOTREXATE THERAPY
Authors: SEYGER MMB VANDENHOOGEN FHJ VANVLIJMENWILLEMS IMJJ VANDEKERKHOF PCM DEJONG EMGJ
Citation: Mmb. Seyger et al., LOCALIZED AND SYSTEMIC SCLERODERMA SHOW DIFFERENT HISTOLOGICAL RESPONSES TO METHOTREXATE THERAPY, Journal of investigative dermatology, 110(4), 1998, pp. 602-602
DECREASED STAINING OF HEPARAN-SULFATE IN NON-LESIONAL SKIN OF A SUBGROUP OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: SEYGER MMB VANBRUGGEN MCJ HARDEMAN HK VANDENHOOGEN FHJ BERDEN JHM VANDENBORN J DEJONG EMGJ
Citation: Mmb. Seyger et al., DECREASED STAINING OF HEPARAN-SULFATE IN NON-LESIONAL SKIN OF A SUBGROUP OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Acta dermato-venereologica, 78(5), 1998, pp. 326-330
EPICUTANEOUS APPLICATION OF LEUKOTRIENE B-4 INDUCES PATTERNS OF TENASCIN AND A HEPARAN-SULFATE PROTEOGLYCAN EPITOPE THAT ARE TYPICAL FOR PSORIATIC LESIONS
Authors: SEYGER MMB VANPELT JPA VANDENBORN J LATIJNHOUWERS MA DEJONG EMGJ
Citation: Mmb. Seyger et al., EPICUTANEOUS APPLICATION OF LEUKOTRIENE B-4 INDUCES PATTERNS OF TENASCIN AND A HEPARAN-SULFATE PROTEOGLYCAN EPITOPE THAT ARE TYPICAL FOR PSORIATIC LESIONS, Archives of dermatological research, 289(6), 1997, pp. 331-336
RELIABILITY OF 2 METHODS TO ASSESS MORPHEA - SKIN SCORING AND THE USEOF A DUROMETER
Authors: SEYGER MMB VANDENHOOGEN FHJ DEBOO T DEJONG EMGJ
Citation: Mmb. Seyger et al., RELIABILITY OF 2 METHODS TO ASSESS MORPHEA - SKIN SCORING AND THE USEOF A DUROMETER, Journal of the American Academy of Dermatology, 37(5), 1997, pp. 793-796
DECREASED STAINING OF HEPARAN-SULFATE PROTEOGLYCANS IN NON LESIONAL SKIN OF A SUBGROUP OF SLE PATIENTS
Authors: SEYGER MMB VANBRUGGEN MCJ HARDEMAN H VANDENHOOGEN FHJ BERDEN JHM VANDENBORN J DEJONG EMGJ
Citation: Mmb. Seyger et al., DECREASED STAINING OF HEPARAN-SULFATE PROTEOGLYCANS IN NON LESIONAL SKIN OF A SUBGROUP OF SLE PATIENTS, Journal of investigative dermatology, 109(3), 1997, pp. 421-421
ALTERED DISTRIBUTION OF HEPARAN-SULFATE PROTEOGLYCANS IN PSORIASIS
Authors: SEYGER MMB VANDENBORN J SCHALKWIJK J VANDEKERKHOF PCM DEJONG EMGJ
Citation: Mmb. Seyger et al., ALTERED DISTRIBUTION OF HEPARAN-SULFATE PROTEOGLYCANS IN PSORIASIS, Acta dermato-venereologica, 77(2), 1997, pp. 105-109
12Q13, A NEW RECURRENT BREAKPOINT IN ACUTE NONLYMPHOBLASTIC LEUKEMIA
Authors: SEYGER MMB RITTERBACH J CREUTZIG U GNEKOW AK GOBEL U GRAF N REITER A LAMPERT F HARBOTT J
Citation: Mmb. Seyger et al., 12Q13, A NEW RECURRENT BREAKPOINT IN ACUTE NONLYMPHOBLASTIC LEUKEMIA, Cancer genetics and cytogenetics, 80(1), 1995, pp. 23-28
EXPRESSION OF HEPARANSULPHATE PROTEOGLYCANS IN PSORIASIS
Authors: DEJONG EMGL VANDENBORN J SEYGER MMB BERDEN JHM ANDRIESSEN MPM SCHALKWIJK J
Citation: Emgl. Dejong et al., EXPRESSION OF HEPARANSULPHATE PROTEOGLYCANS IN PSORIASIS, Journal of investigative dermatology, 105(3), 1995, pp. 465-465
Risultati: 1-10 |